Novartis AG
Market Cap
$299.09B
P/E Ratio
21.64
EPS
$7.15
Dividend Yield
2.79%
52-Week Range
$97.72 — $170.46
Volume
1.36M
Avg Volume
2.26M
Beta
0.50
P/E (TTM)
21.64
Forward P/E
17.58
PEG Ratio
-10.77
P/S (TTM)
5.47
P/B (TTM)
6.69
P/FCF
173.61
EV/EBITDA
56.69x
EV/Sales
—
ROE (TTM)
0.33%
ROA (TTM)
0.12%
ROIC
0.04%
Gross Margin
0.76%
Operating Margin
0.31%
Net Margin
0.18%
Debt/Equity
0.80
Current Ratio
1.12
EPS Growth (YoY)
-0.10%
Revenue Growth (YoY)
+0.03%
EPS Growth (3Y)
+0.43%
EPS Growth (5Y)
+0.52%
Sales Growth (3Y)
+0.08%
Sales Growth (5Y)
+0.02%
EPS Est (This Year)
$8.80
EPS Est (Next Year)
$9.68
Dividend Yield
—
Annual Dividend
$3.99
Payout Ratio
0.04%
Frequency
—
Ex-Dividend Date
2025-03-12
Cash/Share
$6.05
Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $127.00(-17.9% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
1.93B
Float
1.82B
Free Float %
93.95%
RSI (14)
77.73
SMA 20
$149.12
SMA 50
$141.23
SMA 200
$128.83
ATR (14)
2.83
Volatility (Week)
0.01%
Volatility (Month)
0.01%
Pattern
—
1 Day
+0.73%
1 Week
+5.57%
1 Month
+11.77%
3 Months
+25.21%
6 Months
+33.45%
1 Year
—
YTD
+14.19%
All-Time High
$159.37
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
CH
Exchange
NYSE
IPO Date
1996-11-07
Employees
75883
CEO
Vasant Narasimhan
Index Membership
—
Website
https://www.novartis.com
Novartis AG (NVS) is a healthcare company in the drug manufacturers - general industry listed on the NYSE. With a market capitalization of $299.09B, a P/E ratio of 21.64, and a dividend yield of 2.79%, NVS is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare NVS against other stocks using dozens of fundamental and technical filters.
Novartis AG (NVS) has a trailing twelve-month (TTM) P/E ratio of 21.64. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Novartis AG (NVS) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Novartis AG (NVS) has a market capitalization of $299.09 billion, classifying it as a mega-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Buy" rating on Novartis AG (NVS) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $127.00 implies 17.9% downside from the current price.
Novartis AG (NVS) has returned +14.19% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.